2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
2
Wilms Tumor
1
Multiple Myeloma
1
Hematologic Neoplasms
1
Heart Diseases
1
Cardiotoxicity
1
Interventions
Antineoplastic Agents
3
Nutrition Assessment
2
Mass Screening
2
Echocardiography
2
Blood Specimen Collection
2
liposomal doxorubicin
1
Vitamin E
1
Vitamin D
1
Vital Signs
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Progestins
1
Positron-Emission Tomography
1
Methods
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hormone Replacement Therapy
1
Hematologic Tests
1
Exercise Test
1
Estrogens
1
Estrogen Replacement Therapy
1
Educational Status
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Diagnosis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Diseases
×
Immunomodulating Agents
×
Clear all
NCT03530215
2023-04-13
EROCA
Groupe Hospitalier Pitie-Salpetriere
Completed
500,000 enrolled